EPAD papers identifies expectations related to learning risk status and preferences related to the content, quality, and follow-up of the disclosure process

  Summary: In clinical trials which target pathophysiological mechanisms associated with Alzheimer’s disease, research participants who are recruited based on biomarker test results should be informed about their increased risk of developing Alzheimer’s dementia. This paper presents the results of a qualitative focus group study of attitudes and concerns toward learning information about biomarker-based risk…

EPAD is glad to be featured in the Spanish “Diario Médico” magazine

  On 26 January, the Spanish specialized magazine for physicians “Diario Médico” published an article entitled “Una década de investigación en la prevención del Alzheimer” including an interview of Prof. José Luis Molinuevo, EPAD co-leader and Scientific Director of the BBRC (Barcelonabeta Brain Research Center). BBRC is the institute where the Pasqual Maragall Foundation conducts all…